Satapathy S, Mittal BR, Sood A, Das CK, et al. [(177)Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial. J Nucl Med 2023 Sep 14:jnumed.123.266141. doi: 10.2967/jnumed.123.266141.
PMID: 37709534